Literature DB >> 139202

Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.

B K Bhuyan, T J Fraser, K J Day.   

Abstract

Drug sensitivity and cell cycle parameters of L1210 cells in culture in exponential (10(5) to 4 x 10(5) cells/ml) and plateau phase (greater than 8 x 10(5) cells/ml) of growth were compared. The percentage of cells in G1, S, and G2 + M for exponential and plateau-phase cultures was 24.1, 70.0, and 5.9, and 42.5, 45.6, and 11.9, respectively. These values correspond to those reported previously for early and late L1210 mouse leukemia cells. Cell survival (measured by cloning) after drug exposure showed that actinomycin D, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, chlorozotocin, and streptozocin were all equally lethal to cells in both phases, and 1-beta-D-arabinofuranosylcytosine, high-specific-activity (20Ci/mmole) [3H]thymidine, vincristine, daunomycin, adriamycin, and 5-fluorouracil were more lethal to exponential cells than to plateau-phase cells. The percentage kill by S-phase-specific agents such as 1-beta-D-arabinofuranosylcytosine and[3H]thymidine corresponded well with the percentage of cells in S. Finally, 1,3-bis(2-chloroethyl)-1-nitrosourea was more toxic to plateau cells than to exponential cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 139202

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Cytotoxicity of three novel fluoropyrimidines in cultured L1210 murine lymphocytic leukemia cells.

Authors:  A M Shipp; M H Holshouser; P W Ferguson
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

Review 2.  Distinguishing between resistance, tolerance and persistence to antibiotic treatment.

Authors:  Asher Brauner; Ofer Fridman; Orit Gefen; Nathalie Q Balaban
Journal:  Nat Rev Microbiol       Date:  2016-04       Impact factor: 60.633

3.  Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragment formation on S phase progression in HT29 cells.

Authors:  H Y Tang; K L Weber; T S Lawrence; A K Merchant; J Maybaum
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

4.  Survival and cell cycle kinetics responses of Chinese hamster ovary cells, and clones of human adenocarcinoma of the stomach and astrocytoma to diaziquone (AZQ) in vitro.

Authors:  S C Barranco; G A Schechter; W R Boerwinkle; K A Howell; N H Rubin
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

5.  Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.

Authors:  S Fujimoto; Y Wang; M Ogawa
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 6.  Hypoxia and drug resistance.

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

7.  The effects of 1-methyl-1-nitrosourea on the survival pattern of cycling and noncycling HeLa cells.

Authors:  J Ban; B Brdar; J Sorić
Journal:  J Cancer Res Clin Oncol       Date:  1979-07-27       Impact factor: 4.553

8.  Establishment, characterization and chemosensitivity of two human glioma derived cell lines.

Authors:  G Zupi; A Candiloro; N Laudonio; C Carapella; M Benassi; A Riccio; M Bellocci; C Greco
Journal:  J Neurooncol       Date:  1988-09       Impact factor: 4.130

Review 9.  Some aspects of size-dependent differential drug response in primary and metastatic tumors.

Authors:  I Abe; M Suzuki; K Hori; S Saito; H Sato
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

10.  Comparison of cytostatic sensitivities of L 1210 cells and human stimulated lymphocytes in three cell proliferation assays.

Authors:  F Ali-Osman; H R Maurer
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.